Browsing: Cryptolepis Sanguinolenta

natural cryptolepis sanguinolenta roots 456

First herbal medicine for a clinical trial on COVID-19 treatment by Researchers from the School of Public Health at the Kwame Nkrumah University of Science and Technology has been approved.

The medicine dubbed Cryptolepis Sanguinolenta, locally known as Nibima was approved by the Food and Drugs Authority (FDA) on Monday, February 1, 2021.

Mrs Delese A.A. Darko, the Chief Executive Officer of the FDA confirmed the approval in a statement issued in Accra.

The researchers had earlier submitted a clinical application in search of the Covid-19 treatment.

The application was to assess the safety and efficacy of Cryptolepois Sanguinolenta as a potential treatment of COVID-19.

This follows results from lab studies conducted by the KNUST Research team, which points in the direction of possible clinical benefits.

This is, however, not the first time the medicine is being used.

Also Read: Pandemic, AfCFTA wakeup call for Africa’s pharmaceuticals

The roots of …